Search

everythinglearnresearchcommunity

for

Search:↓

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Finasteride reduces prostate size and PSA levels in young patients.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

CT scans can find serious prostate cancer even when PSA levels are low.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Ganoderma lucidum may help treat enlarged prostate in rats.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Serum triglyceride levels are not linked to prostate cancer risk.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.